Organogenesis Inc.

ORGO | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.48

+$0.08 (+5.71%)

Sep 22, 2026, 1:19 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	37.03M	861K	4.95M	15.53M	94.9M	17.23M
Depreciation & Amortization	26.94M	17.03M	23.45M	10.73M	16.68M	8.18M
Stock-Based Compensation	13.3M	10.58M	9M	6.55M	3.86M	1.66M
Other Working Capital	1.87M	-8.51M	-30.08M	-19.16M	-3.6M	612K
Other Non-Cash Items	35.3M	45.35M	9.59M	24.15M	17.8M	6.03M
Deferred Income Tax	9.5M	-10.72M	2.01M	1.98M	-31.98M	112K
Change in Working Capital	-132.38M	-48.89M	-18.07M	-34.08M	-39.29M	-27.76M
Operating Cash Flow	-10.31M	14.21M	30.92M	24.86M	61.98M	5.47M
Capital Expenditures	-14.15M	-10.03M	-24.36M	-33.9M	-31.22M	-17.68M
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	-5.82M
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-14.15M	-10.03M	-24.36M	-33.9M	-31.22M	-23.5M
Debt Repayment	-1.17M	-67.64M	-5.17M	-3.01M	-2.01M	-15.91M
Common Stock Repurchased	n/a	-25.48M	n/a	n/a	n/a	n/a
Dividend Paid	n/a	-1.8M	n/a	n/a	n/a	n/a
Other Financial Acitivies	-16.35M	1.87M	-332K	814K	-1.22M	-6.35M
Financial Cash Flow	-17.36M	27.64M	-5.51M	-2.2M	-1.04M	42.47M
Net Cash Flow	-41.82M	31.81M	1.05M	-11.24M	29.72M	24.44M
Free Cash Flow	-24.46M	4.18M	6.55M	-9.04M	30.76M	-12.21M
Adj. Free Cash Flow	-37.76M	-6.4M	-2.44M	-15.59M	26.89M	-13.87M
Maintenance CapEx	n/a	n/a	-24.36M	-33.9M	-3.47M	-3.77M
Growth CapEx	-14.15M	-10.03M	n/a	n/a	-27.75M	-13.91M
Owner Earnings	-10.31M	14.21M	6.55M	-9.04M	58.5M	1.7M